PHIO Stock Analysis: Buy, Sell, or Hold?
PHIO - Phio Pharmaceuticals Corp. Common Stock
$1.18
-0.03 (-2.48%)
▼
5d:
+8.26%
30d:
+10.28%
90d:
+8.26%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When PHIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PHIO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PHIO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PHIO is currently trading at $1.18, which is considered extended relative to its 30-day fair value range of $1.00 to $1.12.
Technical Outlook: Technically, PHIO is in a downtrend. Immediate support is located at $1.02, while resistance sits at $1.24.
Market Sentiment: PHIO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.00 (+1086.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PHIO is in a downtrend. Immediate support is located at $1.02, while resistance sits at $1.24.
Market Sentiment: PHIO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.00 (+1086.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.00 -
$1.12
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range (+5.4% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1086.4% below Wall St target ($14.00)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.00 -
$1.12
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.02
Resistance Level
$1.24
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.87
Wall Street Target
$14.00
(+1086.4%)
Share & Embed Analysis
Last updated: August 23, 2026 8:35 AM ET
Data refreshes hourly during market hours. Next update: 9:35 AM
Data refreshes hourly during market hours. Next update: 9:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$109 | 66 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 41 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 27 SELL |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 41 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 49 HOLD |
